Better medicine starts with patient biology.
Deltos reads disease biology from a blood draw, delivering insight for critical decisions.
Medicine is rate-limited by what we can measure in patients.
Traditional biopsies reveal disease biology and guide clinical decisions. However, we can't reach every patient's tissue. Biopsies are:
Invasive
Too risky for critically ill patients and many organ systems
Scarce
Often not enough tissue for diagnosis and deeper characterization
Limited to one site
One small sample, not the full picture of disease across the body
Disease leaves a record in the blood.
When cells are stressed, activated, or dying, they release RNA into the bloodstream. That cell-free RNA (cfRNA) carries a record of what's happening in the tissue it came from, including tissues no biopsy can reach.
From a patient sample to a decision.
Interpret
Teams of AI scientists translate findings to guide the next decision.
Contextualize
Disease models trace signals to the underlying biology.
Read
Purpose-built technology captures disease signals from blood.